| Stat | Detail |
|---|---|
| 47% | of US adults aged 30 and older have periodontitis |
| 20.8% | of patients completed periodontal therapy, but never entered supportive periodontal therapy (SPT) |
| 56% | of those who entered SPT stopped attending after 20 months |
| 1 in 10 | patients maintained regular supportive care over 6 years |
| 2 in 3 | adults don't floss daily — including 1 in 3 who don't floss at all |
Proclaim integrates clinical diagnostics, member engagement, provider networks, and claims analytics into a unified platform.
.svg)
Machine learning models analyze medical and dental claims to identify members at highest risk for untreated periodontal disease, gingivitis, and systemic complications.
Precision salivary diagnostics provide objective pathogen data across all 11 MyPerioPath® pathogens to build a personalized roadmap.
The Proclaim 7-second daily system dramatically improves patient adherence by simplifying complex oral health routines.
Targeted outreach, easy scheduling, and real-time progress tracking increase appropriate utilization among at-risk populations.
Track direct impact between dental interventions and medical cost reduction through advanced attribution modeling.
Access current rates across all states and payer types for CPT to simplify provider operations.
— Dental Benefit Manager
Oral inflammation is a key driver of systemic health risk, yet care approaches vary and homecare remains inconsistent. Without a structured protocol that includes a baseline diagnostic, an easy-to-follow homecare system, and continuous monitoring, both clinicians and patients lack a cohesive system to manage disease and track progress over time.
The Proclaim home care protocol is a program for inflammation management that combines salivary diagnostics powered by OralDNA Labs with the clinical home care experience delivered by Proclaim Health. Together, this end-to-end solution enables:
.svg)
